Short description
CellmAbs provides research and development services on novel anti-cancer treatments.
Description
CellmAbs is a NOVA University of Lisbon spin-off company that was founded in 2019 with the funding of two of Portugal's top Life Science Venture Capital firms.
CellmAbs is a rapidly expanding biotech firm with an international, experienced team that has developed multiple preclinical candidates targeting solid tumors based on a world-class understanding of cancer-specific glycan targets.v
Last funding
Noaccessforu
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Lisbon, Lisboa, Portugal, Europe
Founded on
June 5, 2019
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Cannot Access, Noaccessforu
Sign in for full access
Founders
Nuno Prego Ramos, Paula Videira